Literature DB >> 2715558

Rate of progression of Alzheimer's disease.

E Ortof1, H A Crystal.   

Abstract

We determined rate of cognitive decline in 54 patients with a clinical diagnosis of Alzheimer's disease. Cognitive ability was assessed by score on the Blessed test of orientation, memory, and concentration. Rate of progression was defined as the change in score on the Blessed test per year and was computed using a linear regression analysis. Only patients who had been followed for at least one year and who had at least three separate evaluations were included in the study. The overall rate of progression was 4.1 Blessed points per year. Age of onset, duration of illness, and family history of dementia had no significant influence on rate of progression.

Entities:  

Mesh:

Year:  1989        PMID: 2715558     DOI: 10.1111/j.1532-5415.1989.tb05681.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  4 in total

1.  Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles.

Authors:  U M Mann; E Mohr; M Gearing; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

2.  Factors affecting the age of onset and rate of progression of Alzheimer's disease.

Authors:  J V Bowler; D G Munoz; H Merskey; V Hachinski
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

3.  Description of the Method for Evaluating Digital Endpoints in Alzheimer Disease Study: Protocol for an Exploratory, Cross-sectional Study.

Authors:  Jelena Curcic; Vanessa Vallejo; Jennifer Sorinas; Oleksandr Sverdlov; Jens Praestgaard; Mateusz Piksa; Mark Deurinck; Gul Erdemli; Maximilian Bügler; Ioannis Tarnanas; Nick Taptiklis; Francesca Cormack; Rebekka Anker; Fabien Massé; William Souillard-Mandar; Nathan Intrator; Lior Molcho; Erica Madero; Nicholas Bott; Mieko Chambers; Josef Tamory; Matias Shulz; Gerardo Fernandez; William Simpson; Jessica Robin; Jón G Snædal; Jang-Ho Cha; Kristin Hannesdottir
Journal:  JMIR Res Protoc       Date:  2022-08-10

4.  MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer's Disease.

Authors:  Paul M McKeever; Raphael Schneider; Foad Taghdiri; Anna Weichert; Namita Multani; Robert A Brown; Adam L Boxer; Anna Karydas; Bruce Miller; Janice Robertson; Maria Carmela Tartaglia
Journal:  Mol Neurobiol       Date:  2018-03-30       Impact factor: 5.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.